We then had to increase that patent length in order to be in accordance with the wto. And that meant that pharmaceutical companies held onto their patents longer. Drugs could not go generic. That meant that it drove up costs on health care systems in the entire world in order to more benefit the bottom line of pharmaceutical companies or in other types … (30:54–30:57)
CLAIM
Asserts that longer patent lengths prevented drugs from becoming generic.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
